IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · IEX Real-Time Price · USD
1.180
-0.060 (-4.84%)
At close: May 31, 2024, 4:00 PM
1.190
+0.010 (0.85%)
After-hours: May 31, 2024, 4:00 PM EDT
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $77.74 million as of May 31, 2024. Its market cap has increased by 25.39% in one year.
Market Cap
77.74M
Enterprise Value
-37.93M
1-Year Change
25.39%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $77.74M, a decrease of -78.95%. That is a compound annual growth rate of -45.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 77.70M | -4.90% |
May 30, 2024 | 81.70M | 0.86% |
May 29, 2024 | 81.00M | -4.71% |
May 28, 2024 | 85.00M | 1.55% |
May 24, 2024 | 83.70M | -3.79% |
May 23, 2024 | 87.00M | -0.68% |
May 22, 2024 | 87.60M | -0.45% |
May 21, 2024 | 88.00M | -3.19% |
May 20, 2024 | 90.90M | - |
May 17, 2024 | 90.90M | -1.41% |
May 16, 2024 | 92.20M | -2.12% |
May 15, 2024 | 94.20M | -0.74% |
May 14, 2024 | 94.90M | 2.15% |
May 13, 2024 | 92.90M | -1.38% |
May 10, 2024 | 94.20M | -9.51% |
May 9, 2024 | 104.10M | 5.36% |
May 8, 2024 | 98.80M | -2.66% |
May 7, 2024 | 101.50M | 3.36% |
May 6, 2024 | 98.20M | 0.72% |
May 3, 2024 | 97.50M | -3.27% |
May 2, 2024 | 100.80M | -1.27% |
May 1, 2024 | 102.10M | 6.13% |
Apr 30, 2024 | 96.20M | -2.04% |
Apr 29, 2024 | 98.20M | 4.91% |
Apr 26, 2024 | 93.60M | -1.99% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Serina Therapeutics | 79.17M |
T2 Biosystems | 78.98M |
Cognition Therapeutics | 78.11M |
Journey Medical | 78.05M |
Marinus Pharmaceuticals | 78.00M |
Anixa Biosciences | 77.52M |
HOOKIPA Pharma | 76.66M |
Spero Therapeutics | 76.66M |